INTERPHEX 2019 Keynote Series Presents Session on 3D Printing in Pharma

April 2, 2019

3D printing offers a new design freedom for bio/pharmaceutical manufacturing: whether for “printing” a solid-dosage drug or for creating a piece of equipment for bio/pharmaceutical laboratories or manufacturing facilities.

Pharmaceutical Technology will present the INTERPHEX Keynote Series: 3D Printing Applications in Pharma on Tuesday, April 2, 2019 from 1:30 to 3:00 pm. The session will be held on the show floor at the Innovation Stage and is open to all show attendees.

3D Printing Applications in Pharma

Three-dimensional printing (3DP)-also called additive manufacturing-is increasing in use in a range of healthcare industries, for printing customized prosthetics, for example, and for making models doctors can use to plan a surgery. 3DP also offers a new design freedom for bio/pharmaceutical manufacturing-whether for “printing” a solid-dosage drug or for creating a piece of equipment for bio/pharmaceutical laboratories or manufacturing facilities. 3DP is being used commercially in the pharmaceutical industry today, and additional uses are being investigated for the processes and equipment of tomorrow. 

Moderator: Jennifer Markarian, manufacturing editor, Pharmaceutical Technology

1:30­–2:15 pm3D Printing of Pharmaceuticals and Accelerating Drug Development 

Aprecia Pharmaceutical’s Spritam tablets became the first 3D-printed drug approved by FDA in August 2015, demonstrating the commercial feasability of the company's binder-jet 3D-printing process. This session will discuss how 3D printing of pharmaceuticals provides, in addition to commercial production, an opportunity to speed the drug development process, particularly during clinical trials due to its agile manufacturing process, allowing for rapid prototyping and potentially on-demand production. 

Speaker: Timothy S. Tracy, PhD, CEO of Aprecia Pharmaceuticals

Learn more

2­:15–3 pmAccelerating Additive Manufacturing for the Bio/Pharmaceutical Industry

As precision healthcare demands smaller batches of drugs for a more exact patient population, manufacturing processes must become smaller, faster, and more efficient. 3D printing is one way to jump-start the industry toward that objective. In 2017, GE Healthcare opened a 3D printing lab at its technology center in Uppsala, Sweden to investigate how 3DP can speed the launch of innovative products. GE Healthcare’s R&D executive, Christel Fenge, will spell out her vision of reducing footprint and weight, while increasing reliability in pharmaceutical manufacturing, using additive manufacturing.

Speaker: Christel Fenge, PhD, head of R&D for GE Healthcare, Uppsala, Sweden

Learn more

Click here to see more show information.

Click here and use promo code IPXREG to register for INTERPHEX.